UTHR
NASDAQ · Biotechnology
United Therapeutics Corp
$586.94
+4.48 (+0.77%)
Performance
1D
+0.77%
1W
-2.39%
1M
+6.70%
3M
+14.70%
6M
+1.94%
1Y
+29.30%
YTD
+18.16%
Open$580.52
Previous Close$582.46
Day High$588.66
Day Low$577.26
52W High$614.23
52W Low$432.53
Volume—
Avg Volume558.0K
Market Cap24.27B
P/E Ratio18.52
EPS$27.96
SectorBiotechnology
Technical Indicators
Full analysis →
SMA 50
$535.33
Above
SMA 200
$535.04
Above
RSI (14)
60.2
Neutral
Trend
Golden Cross
Bullish
Analyst Ratings
Strong Buy
22 analysts
Price Target
-84.9% upside
Current
$586.94
$586.94
Target
$88.53
$88.53
$65.70
$88.53 avg
$121.74
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 2.87B | 2.43B | 2.73B |
| Net Income | 1.20B | 917.69M | 406.29M |
| Profit Margin | 41.9% | 39.8% | 14.9% |
| EBITDA | 1.42B | 1.15B | 733.08M |
| Free Cash Flow | — | — | 513.48M |
| Rev Growth | +18.0% | +18.0% | +4.0% |
| Debt/Equity | — | — | 0.52 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $294.16 | +0.29% | 49.3 | 509.50B |
| AMGN | Amgen Inc | $463.66 | -0.34% | 26.5 | 248.84B |
| GILD | Gilead Sciences Inc | $169.91 | +0.35% | — | 208.28B |
| VRTX | Vertex Pharmaceuticals Inc | $550.07 | -0.15% | 34.5 | 137.12B |
| REGN | Regeneron Pharmaceuticals | $911.56 | -0.91% | 19.4 | 93.39B |
| ALNY | Alnylam Pharmaceuticals Inc | $151.28 | -3.40% | 7.7 | 20.98B |